Walleye Capital
RMD icon

Walleye Capital’s ResMed RMD Stock Holding History

Walleye Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.21M Sell
5,400
-200
-4% -$49.8K 0.01% 1901
2025
Q4 		$1.35M Buy
5,600
+1,700
+44% +$435K ﹤0.01% 2190
2025
Q3 		$1.07M Sell
3,900
-5,900
-60% -$1.61M ﹤0.01% 2039
2025
Q2 		$2.53M Sell
9,800
-3,600
-27% -$859K 0.01% 1338
2025
Q1 		$3M Buy
13,400
+5,900
+79% +$1.38M 0.01% 1137
2024
Q4 		$1.72M Sell
7,500
-14,200
-65% -$3.42M ﹤0.01% 1917
2024
Q3 		$5.3M Sell
21,700
-3,100
-13% -$693K 0.01% 1131
2024
Q2 		$4.75M Buy
24,800
+8,000
+48% +$1.62M 0.01% 1331
2024
Q1 		$3.33M Buy
16,800
+8,200
+95% +$1.5M 0.01% 1612
2023
Q4 		$1.48M Buy
8,600
+5,500
+177% +$845K ﹤0.01% 2030
2023
Q3 		$458K Buy
3,100
+500
+19% +$90.4K ﹤0.01% 2884
2023
Q2 		$568K Sell
2,600
-1,500
-37% -$334K ﹤0.01% 2338
2023
Q1 		$898K Buy
+4,100
New +$890K 0.01% 1236
2020
Q1 		– Sell
-100
Closed -$15K – 1530
2019
Q4 		$15K Buy
+100
New +$14.4K ﹤0.01% 1624

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Walleye Capital's RMD Position: Q1 2026 in Review

Walleye Capital opened a new position in ResMed (RMD) in Q1 2026: 3,289 shares worth $738K. The stake represents ﹤0.01% of the portfolio and ranks #2350 among its holdings. This is a return to the name: Walleye Capital previously reported a position in RMD as recently as Q3 2025.

Walleye Capital first reported a position in RMD in Q2 2019 and has held it in 11 quarters since. The position peaked at $6.45M in Q3 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Walleye Capital held 3,289 shares of ResMed worth $738K as of Q1 2026.
  • ResMed was a new Walleye Capital position in Q1 2026.
  • ResMed made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2350 holding.
  • Walleye Capital first reported a position in ResMed in Q2 2019 and has held it in 11 quarters since.
  • Walleye Capital's ResMed position peaked at $6.45M in Q3 2024.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.